Taking the industry lineBMJ 1995; 310 doi: http://dx.doi.org/10.1136/bmj.310.6989.1274 (Published 13 May 1995) Cite this as: BMJ 1995;310:1274
- Joe Collier
Mary Goldring, who has always impressed me in the past, fell apart as she tried to analyse the drugs industry. Pompous, overwordy, lacking intellectual rigour, and using analogies whenever possible (how this infuriates me), she ploughed on for a full hour. There was no clear thread to the programme, and I imagine there will have been many a grazer who flicked back to the VE Day celebrations.
The press release suggested that we would get an analysis of the pharmaceutical industry as a business, and I had hoped for a critical and thoughtful account. We got a series of unrelated, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial